Updated Health Economics Simulation Model of the Lifetime Progression of Multiple Sclerosis in an Australian Setting

Key Points

• The research aims to enhance the health economics simulation model to evaluate multiple sclerosis (MS) progression and interventions.
• Incorporated a larger cohort for improved data reflectiveness.
• Updated inputs related to disease progression and economic factors.
• Enhanced face validity of the simulation model.
• The model offers a clearer assessment of MS's impact on life expectancy.
• Higher accuracy in estimating quality-adjusted life years (QALYs) for MS patients.
• Facilitates more reliable cost-effectiveness analyses of MS interventions.

Abstract